Further analysis revealed that YD treatment significantly reduced the Treg cell population and increased the CD8+ T/Treg cell ratios in tumor‐draining lymph nodes (TDLNs), spleen, and tumor compared to Y45 alone (Figure S8a‐c, Supporting information). Here, CD8A is linked to neoplasm.